Review
Version 1
Preserved in Portico This version is not peer-reviewed
mRNA Vaccines: A Prospective Analysis of Long-term, Multi-target, and Autoimmune Disorders
Version 1
: Received: 30 October 2023 / Approved: 31 October 2023 / Online: 31 October 2023 (05:11:07 CET)
How to cite: Niazi, S. K. mRNA Vaccines: A Prospective Analysis of Long-term, Multi-target, and Autoimmune Disorders. Preprints 2023, 2023101981. https://doi.org/10.20944/preprints202310.1981.v1 Niazi, S. K. mRNA Vaccines: A Prospective Analysis of Long-term, Multi-target, and Autoimmune Disorders. Preprints 2023, 2023101981. https://doi.org/10.20944/preprints202310.1981.v1
Abstract
The new class of mRNA vaccines is studied extensively, leading to many novel prospects based on the pivotal success of vaccines against the SARS-Cov-2 virus. Many novel mechanisms of immune response discovered have led to the possibility of mutation-resistant vaccines by combining multiple conserved epitopes as antigens to manipulate the T-cell and B-cell responses; these antigens can also come from different organisms, providing protection against numerous diseases and of most tremendous significance is the utility of mRNA vaccines in preventing and treating more than 100 autoimmune disorders. This is a significant humanitarian breakthrough given the ease and faster and low cost of mRNA vaccines, being a chemical entity. This paper provides a prospective analysis of mRNA vaccines with much broader applications than anticipated when these vaccines entered treating SARS-Cov-2 infections.
Keywords
T-cell-mediated immunity; vaccines; infectious diseases; viral vectors; mRNA vaccines
Subject
Medicine and Pharmacology, Pharmacology and Toxicology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment